As demonstrated in Figure 3B, all the cancer cell lines that express relatively high levels of Bcl-xL and Mcl-1, and the H23 line, which shows strong Mcl-1 expression and low Bcl-xL expression, demonstrate resistance to various chemotherapy agents including cisplatin, SAHA and ABT-737. This evidence concerns the gene MCL1 and cancer.